{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:49:29Z","timestamp":1791362969845,"version":"4.3.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Core fucosylation, catalyzed by fucosyltransferase 8 (FUT8), plays critical roles in cancer progression, immune evasion, and drug resistance, making it a compelling therapeutic target. However, development of selective FUT8 inhibitors has been hindered by shared substrate specificity of fucosyltransferases. Here, we report the discovery of a previously unrecognized allosteric site on FUT8 and the development of a low-toxicity covalent inhibitor, CAIF (stearic acid-N-hydroxysuccinimide ester-dimethylimidazolium bromide), through structure-based drug design. High-throughput screening and crystallographic studies reveal that small molecules such as NH125 bind to a channel-like allosteric pocket, inducing conformational changes that disrupt FUT8 activity. Leveraging these insights, we design CAIF to covalently target lysine K216 within the allosteric site. CAIF exhibits minimal cytotoxicity and significantly inhibits core fucosylation and cancer cell invasion in cellular assays. This work establishes CAIF as a lead compound for further optimization and development, offering a framework for targeting glycosyltransferases through allosteric and covalent inhibition strategies.<\/jats:p>","DOI":"10.1038\/s41467-026-68971-7","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:36:53Z","timestamp":1770741413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploiting human fucosyltransferase 8 allostery with a covalent inhibitor for core fucosylation suppression"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0168-8115","authenticated-orcid":false,"given":"Jiheng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-578X","authenticated-orcid":false,"given":"Biao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1212","authenticated-orcid":false,"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3448-5494","authenticated-orcid":false,"given":"Pengfei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"68971_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Schjoldager","year":"2020","unstructured":"Schjoldager, K. T., Narimatsu, Y., Joshi, H. J. & Clausen, H. Global view of human protein glycosylation pathways and functions. Nat. Rev. Mol. Cell Biol. 21, 729\u2013749 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"68971_CR2","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.1074\/jbc.M116.720789","volume":"291","author":"Q Yang","year":"2016","unstructured":"Yang, Q. & Wang, L. X. Mammalian alpha-1,6-fucosyltransferase (FUT8) is the sole enzyme responsible for the N-acetylglucosaminyltransferase i-independent core fucosylation of high-mannose N-glycans. J. Biol. Chem. 291, 11064\u201311071 (2016).","journal-title":"J. Biol. Chem."},{"key":"68971_CR3","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1039\/C6OB00586A","volume":"14","author":"AD Calderon","year":"2016","unstructured":"Calderon, A. D. et al. Substrate specificity of FUT8 and chemoenzymatic synthesis of core-fucosylated asymmetric N-glycans. Org. Biomol. Chem. 14, 4027\u20134031 (2016).","journal-title":"Org. Biomol. Chem."},{"key":"68971_CR4","doi-asserted-by":"publisher","first-page":"9431","DOI":"10.1021\/jacs.7b03729","volume":"139","author":"TH Tseng","year":"2017","unstructured":"Tseng, T. H. et al. Substrate preference and interplay of fucosyltransferase 8 and N-acetylglucosaminyltransferases. J. Am. Chem. Soc. 139, 9431\u20139434 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"68971_CR5","doi-asserted-by":"publisher","first-page":"14796","DOI":"10.1074\/jbc.M117.804070","volume":"292","author":"Q Yang","year":"2017","unstructured":"Yang, Q., Zhang, R., Cai, H. & Wang, L. X. Revisiting the substrate specificity of mammalian alpha1,6-fucosyltransferase reveals that it catalyzes core fucosylation of N-glycans lacking alpha1,3-arm GlcNAc. J. Biol. Chem. 292, 14796\u201314803 (2017).","journal-title":"J. Biol. Chem."},{"key":"68971_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ccell.2017.05.007","volume":"31","author":"P Agrawal","year":"2017","unstructured":"Agrawal, P. et al. A systems biology approach identifies FUT8 as a driver of melanoma metastasis. Cancer Cell 31, 804\u2013819 (2017).","journal-title":"Cancer Cell"},{"key":"68971_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22618-x","volume":"12","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer. Nat. Commun. 12, 2672 (2021).","journal-title":"Nat. Commun."},{"key":"68971_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41368-024-00289-w","volume":"16","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression. Int. J. oral. Sci. 16, 26 (2024).","journal-title":"Int. J. oral. Sci."},{"key":"68971_CR9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1073\/pnas.1220425110","volume":"110","author":"CY Chen","year":"2013","unstructured":"Chen, C. Y. et al. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proc. Natl. Acad. Sci. USA 110, 630\u2013635 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68971_CR10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.celrep.2017.07.027","volume":"20","author":"M Okada","year":"2017","unstructured":"Okada, M. et al. Blockage of core fucosylation reduces cell-surface expression of PD-1 and promotes anti-tumor immune responses of T cells. Cell Rep. 20, 1017\u20131028 (2017).","journal-title":"Cell Rep."},{"key":"68971_CR11","first-page":"87","volume":"6","author":"C Mao","year":"2023","unstructured":"Mao, C., Li, J., Feng, L. & Gao, W. Beyond antibody fucosylation: alpha-(1,6)-fucosyltransferase (Fut8) as a potential new therapeutic target for cancer immunotherapy. Antib. Ther. 6, 87\u201396 (2023).","journal-title":"Antib. Ther."},{"key":"68971_CR12","doi-asserted-by":"crossref","unstructured":"Aldonza, M. B. D. et al. Multi-targeted therapy resistance via drug-induced secretome fucosylation. eLife 12, e75191 (2023).","DOI":"10.7554\/eLife.75191"},{"key":"68971_CR13","doi-asserted-by":"crossref","unstructured":"Lopez-Cortes, R., Correa Pardo, I., Muinelo-Romay, L., Fernandez-Briera, A. & Gil-Martin, E. Core fucosylation mediated by the FucT-8 enzyme affects TRAIL-induced apoptosis and sensitivity to chemotherapy in human SW480 and SW620 colorectal cancer cells. Int. J. Mol. Sci. 24, 11879 (2023).","DOI":"10.3390\/ijms241511879"},{"key":"68971_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44960-6","volume":"15","author":"Q Pan","year":"2024","unstructured":"Pan, Q. et al. EGFR core fucosylation, induced by hepatitis C virus, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defenses. Nat. Commun. 15, 652 (2024).","journal-title":"Nat. Commun."},{"key":"68971_CR15","doi-asserted-by":"publisher","first-page":"7828","DOI":"10.1021\/jacs.1c03174","volume":"143","author":"C Li","year":"2021","unstructured":"Li, C. et al. Site-selective chemoenzymatic modification on the core fucose of an antibody enhances its Fcgamma receptor affinity and ADCC activity. J. Am. Chem. Soc. 143, 7828\u20137838 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"68971_CR16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/bit.20151","volume":"87","author":"N Yamane-Ohnuki","year":"2004","unstructured":"Yamane-Ohnuki, N. et al. Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol. Bioeng. 87, 614\u2013622 (2004).","journal-title":"Biotechnol. Bioeng."},{"key":"68971_CR17","doi-asserted-by":"publisher","first-page":"100211","DOI":"10.1016\/j.cellin.2024.100211","volume":"4","author":"Q Pan","year":"2025","unstructured":"Pan, Q. & Zhang, X. L. Roles of core fucosylation modification in immune system and diseases. Cell insight 4, 100211 (2025).","journal-title":"Cell insight"},{"key":"68971_CR18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314026121","volume":"121","author":"PA Gilormini","year":"2024","unstructured":"Gilormini, P. A. et al. A metabolic inhibitor blocks cellular fucosylation and enables production of afucosylated antibodies. Proc. Natl. Acad. Sci. USA 121, e2314026121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68971_CR19","doi-asserted-by":"publisher","first-page":"102676","DOI":"10.1016\/j.jbc.2022.102676","volume":"298","author":"S Tomida","year":"2022","unstructured":"Tomida, S., Nagae, M. & Kizuka, Y. The stem region of alpha1,6-fucosyltransferase FUT8 is required for multimer formation but not catalytic activity. J. Biol. Chem. 298, 102676 (2022).","journal-title":"J. Biol. Chem."},{"key":"68971_CR20","doi-asserted-by":"publisher","first-page":"7992","DOI":"10.1074\/jbc.RA120.013079","volume":"295","author":"S Tomida","year":"2020","unstructured":"Tomida, S. et al. The SH3 domain in the fucosyltransferase FUT8 controls FUT8 activity and localization and is essential for core fucosylation. J. Biol. Chem. 295, 7992\u20138004 (2020).","journal-title":"J. Biol. Chem."},{"key":"68971_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/glycob\/cwl079","volume":"17","author":"H Ihara","year":"2007","unstructured":"Ihara, H. et al. Crystal structure of mammalian alpha1,6-fucosyltransferase, FUT8. Glycobiology 17, 455\u2013466 (2007).","journal-title":"Glycobiology"},{"key":"68971_CR22","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1074\/jbc.RA120.013291","volume":"295","author":"MA Jarva","year":"2020","unstructured":"Jarva, M. A. et al. Structural basis of substrate recognition and catalysis by fucosyltransferase 8. J. Biol. Chem. 295, 6677\u20136688 (2020).","journal-title":"J. Biol. Chem."},{"key":"68971_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14794-z","volume":"11","author":"A Garcia-Garcia","year":"2020","unstructured":"Garcia-Garcia, A. et al. Structural basis for substrate specificity and catalysis of alpha1,6-fucosyltransferase. Nat. Commun. 11, 973 (2020).","journal-title":"Nat. Commun."},{"key":"68971_CR24","doi-asserted-by":"publisher","first-page":"17027","DOI":"10.1074\/jbc.RA120.014625","volume":"295","author":"BM Boruah","year":"2020","unstructured":"Boruah, B. M. et al. Characterizing human alpha-1,6-fucosyltransferase (FUT8) substrate specificity and structural similarities with related fucosyltransferases. J. Biol. Chem. 295, 17027\u201317045 (2020).","journal-title":"J. Biol. Chem."},{"key":"68971_CR25","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1039\/c3cs60056d","volume":"42","author":"Z Tu","year":"2013","unstructured":"Tu, Z., Lin, Y. N. & Lin, C. H. Development of fucosyltransferase and fucosidase inhibitors. Chem. Soc. Rev. 42, 4459\u20134475 (2013).","journal-title":"Chem. Soc. Rev."},{"key":"68971_CR26","doi-asserted-by":"publisher","first-page":"12534","DOI":"10.1002\/anie.201105065","volume":"50","author":"CD Rillahan","year":"2011","unstructured":"Rillahan, C. D., Brown, S. J., Register, A. C., Rosen, H. & Paulson, J. C. High-throughput screening for inhibitors of sialyl- and fucosyltransferases. Angew. Chem. 50, 12534\u201312537 (2011).","journal-title":"Angew. Chem."},{"key":"68971_CR27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nchembio.999","volume":"8","author":"CD Rillahan","year":"2012","unstructured":"Rillahan, C. D. et al. Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. Nat. Chem. Biol. 8, 661\u2013668 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"68971_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/onco.13911","volume":"26","author":"KT Do","year":"2021","unstructured":"Do, K. T. et al. First-in-human, first-in-class, phase I trial of the fucosylation inhibitor SGN-2FF in patients with advanced solid tumors. Oncologist 26, 925\u2013e1918 (2021).","journal-title":"Oncologist"},{"key":"68971_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27355-9","volume":"12","author":"JFA Pijnenborg","year":"2021","unstructured":"Pijnenborg, J. F. A. et al. Fluorinated rhamnosides inhibit cellular fucosylation. Nat. Commun. 12, 7024 (2021).","journal-title":"Nat. Commun."},{"key":"68971_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41419-023-06027-0","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. FDW028, a novel FUT8 inhibitor, impels lysosomal proteolysis of B7-H3 via chaperone-mediated autophagy pathway and exhibits potent efficacy against metastatic colorectal cancer. Cell Death Dis. 14, 495 (2023).","journal-title":"Cell Death Dis."},{"key":"68971_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202414682","volume":"63","author":"Y Manabe","year":"2024","unstructured":"Manabe, Y. et al. Development of a FUT8 inhibitor with cellular inhibitory properties. Angew. Chem. 63, e202414682 (2024).","journal-title":"Angew. Chem."},{"key":"68971_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s42003-022-03825-8","volume":"5","author":"L Pang","year":"2022","unstructured":"Pang, L. et al. Partitioning of the initial catalytic steps of leucyl-tRNA synthetase is driven by an active site peptide-plane flip. Commun. Biol. 5, 883 (2022).","journal-title":"Commun. Biol."},{"key":"68971_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s42003-024-06559-x","volume":"7","author":"H Qiao","year":"2024","unstructured":"Qiao, H. et al. Specific glycine-dependent enzyme motion determines the potency of conformation selective inhibitors of threonyl-tRNA synthetase. Commun. Biol. 7, 867 (2024).","journal-title":"Commun. Biol."},{"key":"68971_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41587-023-01773-0","volume":"42","author":"M van Kempen","year":"2024","unstructured":"van Kempen, M. et al. Fast and accurate protein structure search with Foldseek. Nat. Biotechnol. 42, 243\u2013246 (2024).","journal-title":"Nat. Biotechnol."},{"key":"68971_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nchembio.2381","volume":"13","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. Recognition of EGF-like domains by the Notch-modifying O-fucosyltransferase POFUT1. Nat. Chem. Biol. 13, 757\u2013763 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"68971_CR36","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1038\/emboj.2012.143","volume":"31","author":"CI Chen","year":"2012","unstructured":"Chen, C. I. et al. Structure of human POFUT2: insights into thrombospondin type 1 repeat fold and O-fucosylation. EMBO J. 31, 3183\u20133197 (2012).","journal-title":"EMBO J."},{"key":"68971_CR37","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1039\/C4MD00086B","volume":"5","author":"L Tedaldi","year":"2014","unstructured":"Tedaldi, L. & Wagner, G. K. Beyond substrate analogues: new inhibitor chemotypes for glycosyltransferases. MedChemComm 5, 1106\u20131125 (2014).","journal-title":"MedChemComm"},{"key":"68971_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1021\/acs.accounts.8b00570","volume":"52","author":"S Lu","year":"2019","unstructured":"Lu, S., Shen, Q. & Zhang, J. Allosteric methods and their applications: facilitating the discovery of allosteric drugs and the investigation of allosteric mechanisms. Acc. Chem. Res. 52, 492\u2013500 (2019).","journal-title":"Acc. Chem. Res."},{"key":"68971_CR39","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41589-023-01345-y","volume":"19","author":"R Kadirvelraj","year":"2023","unstructured":"Kadirvelraj, R. et al. Structural basis for Lewis antigen synthesis by the alpha1,3-fucosyltransferase FUT9. Nat. Chem. Biol. 19, 1022\u20131030 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"68971_CR40","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/glycob\/cwx020","volume":"27","author":"BJ McMillan","year":"2017","unstructured":"McMillan, B. J. et al. Structure of human POFUT1, its requirement in ligand-independent oncogenic Notch signaling, and functional effects of Dowling-Degos mutations. Glycobiology 27, 777\u2013786 (2017).","journal-title":"Glycobiology"},{"key":"68971_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-biochem-061516-044805","volume":"88","author":"A Cuesta","year":"2019","unstructured":"Cuesta, A. & Taunton, J. Lysine-targeted inhibitors and chemoproteomic probes. Annu. Rev. Biochem. 88, 365\u2013381 (2019).","journal-title":"Annu. Rev. Biochem."},{"key":"68971_CR42","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nchembio.1867","volume":"11","author":"CH Arrowsmith","year":"2015","unstructured":"Arrowsmith, C. H. et al. The promise and peril of chemical probes. Nat. Chem. Biol. 11, 536\u2013541 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"68971_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67\u201373 (1999).","journal-title":"J. Biomol. Screen."},{"key":"68971_CR44","doi-asserted-by":"crossref","unstructured":"Copeland, R. A. In Evaluation of Enzyme Inhibitors in Drug Discovery 345\u2013382 (2013).","DOI":"10.1002\/9781118540398"},{"key":"68971_CR45","doi-asserted-by":"publisher","first-page":"115865","DOI":"10.1016\/j.bmc.2020.115865","volume":"29","author":"A Thorarensen","year":"2021","unstructured":"Thorarensen, A. et al. The advantages of describing covalent inhibitor in vitro potencies by IC(50) at a fixed time point. IC(50) determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimization. Bioorg. Med. Chem. 29, 115865 (2021).","journal-title":"Bioorg. Med. Chem."},{"key":"68971_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13058-017-0904-8","volume":"19","author":"CF Tu","year":"2017","unstructured":"Tu, C. F., Wu, M. Y., Lin, Y. C., Kannagi, R. & Yang, R. B. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-beta receptor core fucosylation. Breast Cancer Res. 19, 111 (2017).","journal-title":"Breast Cancer Res."},{"key":"68971_CR47","doi-asserted-by":"crossref","unstructured":"Tai, R. Z. & Zhao, Z. T. Overview of SSRF phase-II beamlines. Nuclear Sci. Techniq. 35, 137 (2024).","DOI":"10.1007\/s41365-024-01487-1"},{"key":"68971_CR48","doi-asserted-by":"crossref","unstructured":"Liu, K. et al. BL02U1: the relocated macromolecular crystallography beamline at the Shanghai Synchrotron Radiation Facility. Nuclear Sci. Techniq. 34, 193 (2023).","DOI":"10.1007\/s41365-023-01348-3"},{"key":"68971_CR49","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1107\/S1600576719001183","volume":"52","author":"F Yu","year":"2019","unstructured":"Yu, F. et al. An automatic data-processing and experiment information management system for biological macromolecular crystallography beamlines. J. Appl. Crystallogr. 52, 472\u2013477 (2019).","journal-title":"J. Appl. Crystallogr."},{"key":"68971_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1107\/S0907444909042589","volume":"66","author":"A Vagin","year":"2010","unstructured":"Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 22\u201325 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"68971_CR51","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"68971_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"68971_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1-2","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"68971_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"68971_CR55","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"68971_CR56","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple Ligand-Protein Interaction Diagrams for Drug Discovery. J. Chem. Inf. Model. 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68971-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:02:18Z","timestamp":1773932538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68971-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68971"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68971-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2607"}}